Patents by Inventor Ruth A. Modzelewski

Ruth A. Modzelewski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6974791
    Abstract: Peptide motifs which define specificity of tumor-derived endothelial cells. These peptides possess a charge motif of positive-positive-hydrophobic which is important in determining the specificity of binding to tumor-derived endothelium. The specific molecular peptide motifs will facilitate diverse therapeutic and diagnostic applications including: anti-angiogenic therapies to be used in alone or in conjunction with standard therapies; imaging tools for both detection of very small metastasis that are undetectable by current techniques; for monitoring tumor response; for targeting and directing chemotherapy drugs to the tumor; for treatment of chronic inflammatory diseases such as rheumatoid arthritis and psoriasis, for treating some forms of blindness; as well as other diagnostic and therapeutic applications.
    Type: Grant
    Filed: March 16, 2001
    Date of Patent: December 13, 2005
    Assignee: The University of Pittsburgh
    Inventors: Michael K. Wong, Ruth A. Modzelewski, Charles Komen Brown, Candace S. Johnson, Donald L. Trump
  • Publication number: 20020058615
    Abstract: Peptide motifs which define specificity of tumor-derived endothelial cells. These peptides possess a charge motif of positive-positive-hydrophobic which is important in determining the specificity of binding to tumor-derived endothelium. The specific molecular peptide motifs will facilitate diverse therapeutic and diagnostic applications including: anti-angiogenic therapies to be used in alone or in conjunction with standard therapies; imaging tools for both detection of very small metastasis that are undetectable by current techniques; for monitoring tumor response; for targeting and directing chemotherapy drugs to the tumor; for treatment of chronic inflammatory diseases such as rheumatoid arthritis and psoriasis, for treating some forms of blindness; as well as other diagnostic and therapeutic applications.
    Type: Application
    Filed: March 16, 2001
    Publication date: May 16, 2002
    Inventors: Michael K. Wong, Ruth A. Modzelewski, Charles Komen Brown, Candace S. Johnson, Donald L. Trump